Beta-cell replacement in immunosuppressed recipients: Old and new clinical indications

Federico Bertuzzi, Camillo Ricordi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Islet transplantation is an appealing procedure able to improve glycemic control in type 1 diabetic patients. However, the possible side effects that may be induced by immunosuppressive therapy limit its application to a select number of patients for whom the risk of immunosuppressants' side effects can be justified. For patients with type 1 diabetes mellitus-who will take immunosuppressants regardless, as they require a solid organ transplant-islet infusion can be an interesting therapeutic option for improving metabolic compensation, whenever pancreas transplant is not possible. Hence, islet infusion can be an important therapeutic option for patients with secondary diabetes mellitus even when a minor pancreatic endocrine function remains. For these patients, results may be better than those obtained with islet infusion for patients with type 1 diabetes mellitus thanks to the lack of autoimmune reaction to the infused islets. The final result is the improvement of the glycemic compensation and most likely also an extension of the graft survival.

Original languageEnglish
Pages (from-to)171-176
Number of pages6
JournalActa Diabetologica
Volume44
Issue number4
DOIs
StatePublished - Dec 1 2007

Fingerprint

Immunosuppressive Agents
Type 1 Diabetes Mellitus
Transplants
Islets of Langerhans Transplantation
Graft Survival
Pancreas
Diabetes Mellitus
Therapeutics

Keywords

  • Hemosiderosis
  • Islet transplantation
  • Mucoviscidosis
  • Secondary diabetes mellitus
  • Type 1 diabetes mellitus

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Beta-cell replacement in immunosuppressed recipients : Old and new clinical indications. / Bertuzzi, Federico; Ricordi, Camillo.

In: Acta Diabetologica, Vol. 44, No. 4, 01.12.2007, p. 171-176.

Research output: Contribution to journalArticle

@article{9e158f5110804c50a065e5132ca2243e,
title = "Beta-cell replacement in immunosuppressed recipients: Old and new clinical indications",
abstract = "Islet transplantation is an appealing procedure able to improve glycemic control in type 1 diabetic patients. However, the possible side effects that may be induced by immunosuppressive therapy limit its application to a select number of patients for whom the risk of immunosuppressants' side effects can be justified. For patients with type 1 diabetes mellitus-who will take immunosuppressants regardless, as they require a solid organ transplant-islet infusion can be an interesting therapeutic option for improving metabolic compensation, whenever pancreas transplant is not possible. Hence, islet infusion can be an important therapeutic option for patients with secondary diabetes mellitus even when a minor pancreatic endocrine function remains. For these patients, results may be better than those obtained with islet infusion for patients with type 1 diabetes mellitus thanks to the lack of autoimmune reaction to the infused islets. The final result is the improvement of the glycemic compensation and most likely also an extension of the graft survival.",
keywords = "Hemosiderosis, Islet transplantation, Mucoviscidosis, Secondary diabetes mellitus, Type 1 diabetes mellitus",
author = "Federico Bertuzzi and Camillo Ricordi",
year = "2007",
month = "12",
day = "1",
doi = "10.1007/s00592-007-0020-9",
language = "English",
volume = "44",
pages = "171--176",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Casa Editrice II Ponte",
number = "4",

}

TY - JOUR

T1 - Beta-cell replacement in immunosuppressed recipients

T2 - Old and new clinical indications

AU - Bertuzzi, Federico

AU - Ricordi, Camillo

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Islet transplantation is an appealing procedure able to improve glycemic control in type 1 diabetic patients. However, the possible side effects that may be induced by immunosuppressive therapy limit its application to a select number of patients for whom the risk of immunosuppressants' side effects can be justified. For patients with type 1 diabetes mellitus-who will take immunosuppressants regardless, as they require a solid organ transplant-islet infusion can be an interesting therapeutic option for improving metabolic compensation, whenever pancreas transplant is not possible. Hence, islet infusion can be an important therapeutic option for patients with secondary diabetes mellitus even when a minor pancreatic endocrine function remains. For these patients, results may be better than those obtained with islet infusion for patients with type 1 diabetes mellitus thanks to the lack of autoimmune reaction to the infused islets. The final result is the improvement of the glycemic compensation and most likely also an extension of the graft survival.

AB - Islet transplantation is an appealing procedure able to improve glycemic control in type 1 diabetic patients. However, the possible side effects that may be induced by immunosuppressive therapy limit its application to a select number of patients for whom the risk of immunosuppressants' side effects can be justified. For patients with type 1 diabetes mellitus-who will take immunosuppressants regardless, as they require a solid organ transplant-islet infusion can be an interesting therapeutic option for improving metabolic compensation, whenever pancreas transplant is not possible. Hence, islet infusion can be an important therapeutic option for patients with secondary diabetes mellitus even when a minor pancreatic endocrine function remains. For these patients, results may be better than those obtained with islet infusion for patients with type 1 diabetes mellitus thanks to the lack of autoimmune reaction to the infused islets. The final result is the improvement of the glycemic compensation and most likely also an extension of the graft survival.

KW - Hemosiderosis

KW - Islet transplantation

KW - Mucoviscidosis

KW - Secondary diabetes mellitus

KW - Type 1 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=36249030051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36249030051&partnerID=8YFLogxK

U2 - 10.1007/s00592-007-0020-9

DO - 10.1007/s00592-007-0020-9

M3 - Article

C2 - 17924054

AN - SCOPUS:36249030051

VL - 44

SP - 171

EP - 176

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 4

ER -